enVVeno Medical Corporation – Filings and Transcripts

NASDAQ: NVNO
Share price (3/17/26): $11.00
Market cap (3/17/26): $7.212 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024 – amended

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration – amended

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Northstrive Fund II LP

Perceptive Advisors LLC

News Filter

Regains Compliance With Nasdaq Minimum Bid Price Requirement

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Shareholder Vote Results, Financial Statements or Exhibits

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Receives Unfavorable Appeal Decision From the FDA for the VenoValve

Proxies Filter

Preliminary revised proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC